Non-invasive advantage Target healthcare systems seeking safer, non-invasive coronary artery disease diagnostics to reduce unnecessary invasive angiographies and associated costs.

Global impact award Leverage recent international awards and recognition to build credibility with hospitals, clinics, and investors looking for validated, cutting-edge diagnostic technology.

Growing footprint Company size suggests scalable operations with room to expand partnerships across hospitals, research institutions, and regional distributors as demand for faster CAD diagnostics grows.

Financial leverage Revenue in the low-to-mid multi-million range indicates capacity for pilot programs, co-development funding, and performance-based pricing models with health systems.

Tech stack fit Emphasize compatibility with enterprise IT environments (Azure, Salesforce, Grafana, Kubernetes) to align with digital health transformation initiatives and data integration needs at care networks.